Compare NGL FINE CHM with Jubilant Pharmova - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs JUBILANT PHARMOVA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM JUBILANT PHARMOVA NGL FINE CHM/
JUBILANT PHARMOVA
 
P/E (TTM) x 25.7 13.7 187.8% View Chart
P/BV x 10.7 2.0 535.8% View Chart
Dividend Yield % 0.1 0.8 7.8%  

Financials

 NGL FINE CHM   JUBILANT PHARMOVA
EQUITY SHARE DATA
    NGL FINE CHM
Mar-21
JUBILANT PHARMOVA
Mar-21
NGL FINE CHM/
JUBILANT PHARMOVA
5-Yr Chart
Click to enlarge
High Rs1,7851,047 170.5%   
Low Rs255251 101.5%   
Sales per share (Unadj.) Rs417.4559.1 74.7%  
Earnings per share (Unadj.) Rs91.851.8 177.3%  
Cash flow per share (Unadj.) Rs105.380.1 131.4%  
Dividends per share (Unadj.) Rs1.755.00 35.0%  
Avg Dividend yield %0.20.8 22.3%  
Book value per share (Unadj.) Rs249.9297.6 84.0%  
Shares outstanding (eoy) m6.18159.28 3.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.41.2 210.4%   
Avg P/E ratio x11.112.5 88.6%  
P/CF ratio (eoy) x9.78.1 119.6%  
Price / Book Value ratio x4.12.2 187.1%  
Dividend payout %1.99.7 19.7%   
Avg Mkt Cap Rs m6,301103,365 6.1%   
No. of employees `000NANA-   
Total wages/salary Rs m28121,728 1.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2,58089,055 2.9%  
Other income Rs m80298 26.9%   
Total revenues Rs m2,66089,354 3.0%   
Gross profit Rs m80118,699 4.3%  
Depreciation Rs m834,516 1.8%   
Interest Rs m222,473 0.9%   
Profit before tax Rs m77612,008 6.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2093,764 5.5%   
Profit after tax Rs m5678,244 6.9%  
Gross profit margin %31.121.0 147.9%  
Effective tax rate %26.931.3 85.8%   
Net profit margin %22.09.3 237.5%  
BALANCE SHEET DATA
Current assets Rs m1,24529,525 4.2%   
Current liabilities Rs m42110,488 4.0%   
Net working cap to sales %31.921.4 149.4%  
Current ratio x3.02.8 105.0%  
Inventory Days Days5113 405.3%  
Debtors Days Days53,138,66734 158,129,802.6%  
Net fixed assets Rs m83258,109 1.4%   
Share capital Rs m31159 19.4%   
"Free" reserves Rs m1,51447,248 3.2%   
Net worth Rs m1,54547,407 3.3%   
Long term debt Rs m6125,640 0.2%   
Total assets Rs m2,07887,634 2.4%  
Interest coverage x36.25.9 618.3%   
Debt to equity ratio x00.5 7.3%  
Sales to assets ratio x1.21.0 122.2%   
Return on assets %28.412.2 231.9%  
Return on equity %36.717.4 211.2%  
Return on capital %49.719.8 250.6%  
Exports to sales %75.50-   
Imports to sales %9.710.2 95.1%   
Exports (fob) Rs m1,947NA-   
Imports (cif) Rs m2519,117 2.8%   
Fx inflow Rs m1,97711,207 17.6%   
Fx outflow Rs m2819,117 3.1%   
Net fx Rs m1,6962,090 81.2%   
CASH FLOW
From Operations Rs m27417,843 1.5%  
From Investments Rs m-246-7,390 3.3%  
From Financial Activity Rs m-11-17,094 0.1%  
Net Cashflow Rs m17-7,289 -0.2%  

Share Holding

Indian Promoters % 73.8 46.5 158.7%  
Foreign collaborators % 0.0 4.2 -  
Indian inst/Mut Fund % 0.0 24.2 -  
FIIs % 0.0 23.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.2 49.3 53.1%  
Shareholders   10,832 113,776 9.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   ALEMBIC PHARMA  ADVANCED ENZYME TECHNOLOGIES  TYCHE INDUSTRIES  CADILA HEALTHCARE  ADESHWAR MEDITEX  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

NGL FINE CHM 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of NGL FINE CHM for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of NGL FINE CHM. Also includes updates on the valuation of NGL FINE CHM.

JUBILANT PHARMOVA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of JUBILANT PHARMOVA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT PHARMOVA . Also includes updates on the valuation of JUBILANT PHARMOVA .

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY20); Net Profit Down 24.0% (Quarterly Result Update)

Feb 1, 2020 | Updated on Feb 1, 2020

For the quarter ended December 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 24.0% YoY). Sales on the other hand came in at Rs 23 bn (down 2.6% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY20); Net Profit Up 358.8% (Quarterly Result Update)

Jun 1, 2020 | Updated on Jun 1, 2020

For the quarter ended March 2020, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 358.8% YoY). Sales on the other hand came in at Rs 24 bn (up 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NGL FINE CHM SHARE PRICE


Nov 26, 2021 (Close)

TRACK NGL FINE CHM

  • Track your investment in NGL FINE CHM with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NGL FINE CHM - ANUH PHARMA COMPARISON

COMPARE NGL FINE CHM WITH

MARKET STATS